Trials / Completed
CompletedNCT02374684
Tolerability, Safety and Pharmacokinetic Study Of Methosulide in Healthy Adult Subjects
A Within-group Randomized, Double-Blind, Placebo-Controlled, Single/ Multiple Dose Study to Assess the Safety , Tolerability, Pharmacokinetics and Food Effect of Methosulide After Oral Administration In Healthy Adult Subjects.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 92 (actual)
- Sponsor
- Hubei Biological Medicine Industrial Technology Institute Co., Ltd. · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the safety and tolerability, and to evaluate the pharmacokinetic characteristics and food effect of Methosulide after oral administration in healthy adult subjects.
Detailed description
1. Dose-escalation study of single oral administration of Methosulide in healthy adults to assess the safety and tolerability. 2. Multiple-dose study of Methosulide in healthy adults to assess the safety and tolerability. 3. Dose-escalation study of single oral administration of Methosulide in healthy adults to evaluate the pharmacokinetic characteristics 4. Multiple-dose study of Methosulide in healthy adults to evaluate the pharmacokinetics characteristics 5. Single dose,and cross-over study of Methosulide in healthy adults to evaluate the pharmacokinetic characteristics and effect of food.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methosulide | Tolerability Study: Period I:Single oral administration,dose-escalation of Methosulide(six dose groups:25mg-250mg) Period II:Repeated oral administration of Methosulide(group 1:MTD(maximum tolerated dose)/250mg ,group 2:depending on the adverse drug reaction,150mg/250mg) Pharmacokinetic Study: Period I:Single oral administration,dose-escalation of Methosulide(three dose groups:50mg,100mg,200mg/250mg) Period II:Repeated oral administration of Methosulide(group 1:MTD(maximum tolerated dose)/250mg ,group 2:depending on the adverse drug reaction,150mg/250mg) Food Effect on the Pharmacokinetics: single dose(100mg),two status(Feeding and fasting), washout period(7 days) |
| DRUG | Placebo | Placebo to match with experimental groups |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2016-02-01
- Completion
- 2016-02-01
- First posted
- 2015-03-02
- Last updated
- 2016-02-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02374684. Inclusion in this directory is not an endorsement.